Efrat Ben-Zeev

Title: Efrat Ben-Zeev: Innovator in Kinase Modulation

Introduction

Efrat Ben-Zeev is a notable inventor based in Kiryat Motzkin, Israel. He has made significant contributions to the field of biotechnology, particularly in the modulation of kinase signaling pathways. With a total of 2 patents, his work has the potential to impact various medical conditions.

Latest Patents

Efrat's latest patents include innovative approaches to kinase modulation. The first patent, titled "Compositions and methods for modulating a kinase," focuses on compounds and methods for influencing components of a kinase signaling cascade. The second patent, "Sulfonamides for the modulation of PKM2," relates to sulfonamide compounds and methods for activating PKM2. These inventions are particularly useful in treating or preventing diseases such as cancer, cell proliferative disorders, inflammatory disorders, metabolic disorders, and immune system disorders.

Career Highlights

Throughout his career, Efrat has worked with several prominent companies in the pharmaceutical industry. Notably, he has been associated with Dynamix Pharmaceuticals Ltd. and Clevexel Pharma. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Efrat has collaborated with talented individuals in his field, including Oren Becker and Alina Shitrit. Their combined efforts have fostered advancements in the research and development of therapeutic solutions.

Conclusion

Efrat Ben-Zeev's contributions to kinase modulation highlight his role as an influential inventor in biotechnology. His patents and collaborations reflect a commitment to addressing critical health challenges through innovative solutions.